Edition:
United States

Cochlear Ltd (COH.AX)

COH.AX on Australia Stock Exchange

141.85AUD
28 Sep 2016
Change (% chg)

$1.14 (+0.81%)
Prev Close
$140.71
Open
$141.00
Day's High
$141.95
Day's Low
$140.38
Volume
121,221
Avg. Vol
208,881
52-wk High
$144.12
52-wk Low
$81.35

COH.AX

Chart for COH.AX

About

Cochlear Limited is engaged in providing implantable hearing solutions. The Company's implant systems comprise an implant, which is inserted during surgery and an external sound processor. The Company operates through three segments, based on geographical basis: Americas, EMEA and Asia Pacific. Americas includes the United... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $8,077.16
Shares Outstanding(Mil.): 57.40
Dividend: 1.20
Yield (%): 1.63

Financials

  COH.AX Industry Sector
P/E (TTM): 42.64 36.94 36.20
EPS (TTM): 3.30 -- --
ROI: 32.06 12.47 13.87
ROE: 47.00 14.79 14.78

BRIEF-Cochlear says U.S. FDA approved nucleus implants for magnetic resonance imaging use up to 3.0t

* Says U.S. FDA approved nucleus implants for magnetic resonance imaging use up to 3.0T with magnet removed

Aug 22 2016

REFILE-UPDATE 1-Australia's Cochlear posts 30 percent profit jump

SYDNEY, Aug 9 Cochlear Ltd, the world's top hearing implants maker, posted a 30 percent rise in annual net profit, meeting its guidance on strong sales growth, and forecast a 15 percent profit rise in the current year.

Aug 08 2016

Australia shares set to open slightly higher, NZ flat

MELBOURNE, Aug 9 Australian shares are poised to open a touch higher on Tuesday, buoyed by iron ore, metals and oil prices, with results from no.4 lender ANZ and hearing implant maker Cochlear potentially lending support. Local share price index futures rose 0.2 percent to 5,494.0, but that was a 43.8-point discount to the underlying S&P/ASX 200 index close. The benchmark climbed 0.7 percent on Monday. New Zealand's benchmark S&P/NZX 50 index slipped 1.5 points to 7,346.8 i

Aug 08 2016

Australia's Cochlear meets guidance with 30 pct profit rise

SYDNEY, Aug 8 Cochlear Ltd, the world's top hearing implants maker, met its market guidance to post a net income of A$188.9 million ($144.53 million) for the year to June 30, an increase of 30 percent.

Aug 08 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Sadif Analytics Prime
$25.00
Provider : MacroRisk Analytics/EconomicInvestor
$25.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.